Diabetes treatment

English

In the spirit of patient centeredness


Angus Forbes

Are the latest treatment innovations enough for people living with diabetes in the 21st century? How can the medical profession utilise current technologies and treatment innovations without losing touch with patient values and the power of compassion and insight?

The role of diabetes technology in children and youth: getting connected for better control


Francine R. Kaufman

Debate - Insulin pump therapy: a matter of choice?

Caregiver reports of provider recommended frequency of blood glucose monitoring and actual testing frequency for youth with type 1 diabetes

 

Joyce P. Yi-Frazier and colleagues for the SEARCH for Diabetes in Youth Study Group
 

Diversity, debate and new directions

Targeting today’s most contemporary issues, the Basic and Clinical Science Stream may provide this year’s Congress with the biggest buzz, especially in areas of obesity, diabetes complications and new treatment strategies. A range of provocative topics including debates about driving type 2 diabetes prevention and bariatric surgery will be presented. Noteworthy speakers will discuss new treatment options for both types of diabetes and present the latest results of clinical trials. Mark Cooper and Sophia Zoungas talk about the exciting programme this year.


Gestational diabetes – an update from India

In recent decades, more women of a reproductive age have diabetes, and more pregnancies are complicated by pre-existing diabetes especially in low- and middle-income countries (LMICs). Also of concern is gestational diabetes mellitus (GDM) - the type of diabetes that is first recognized during pregnancy and affects up to 15% of women worldwide.


Guidelines for type 2 diabetes - designed to help newly diagnosed children and adolescents

The prevalence of childhood obesity has increased dramatically worldwide with potentially dire consequences to the health of children and to their future. Drs. Warren Lee of Singapore and Stuart Brink of the USA introduce the new American Academy of Pediatrics guidelines for newly diagnosed type 2 diabetes in children and adolescents, explaining how the evidence-based recommendations are essential for all physicians involved in the care of children.


New treatments for type 2 diabetes – what is on the horizon?

Worldwide, more than half the people with type 2 diabetes have blood glucose concentrations that are too high, leading to a greater risk of complications. This is partly because many existing treatments have limitations.

Needlestick injury prevention – puncturing the myths

Issues relating to people with diabetes injecting themselves with insulin quite rightly are an important focus of diabetes care. Concerns include avoiding the complications of inaccurate dosing, and ensuring the proper care of injection sites and correct use of blood glucose selfmonitoring. The current implementation of the 2010 EU Directive on sharps injury prevention, places the spotlight of attention on the safety and protection of healthcare professionals when they are administering treatment to people with diabetes. Questions arise over the risks to the diabetes specialist.

Making progress with immune therapies for type 1 diabetes

Thirty-five years on from the demonstration that type 1 diabetes has an autoimmune basis, we have learned an enormous amount about the disease. We know its genetic basis (immune genes), its pathological basis (immune cells) and we would expect to be converting this insight into therapeutic advances (immunebased). Certainly, the field of immunotherapy for type 1 diabetesis very active. Here, Mark Peakman reviews the progress being made and scans the horizon for the mostlikely future breakthroughs.


Pages